Predictive discovery of first-in-class biologics

Overview

Partnering is an important component of Compugen’s business strategy. The Company’s business model is to maximize the commercial value of its unique systematic discovery capability by entering into various forms of revenue-sharing collaborations for its product candidates at both early and later stages of development. We seek opportunities to strategically partner our programs and unique discovery capabilities to create value for the Company and our pharma partners, and as well as to further advance the development and commercialization of our discoveries.

Our goal is to selectively partner and collaborate with top pharma and biotech companies to advance our broad portfolio of novel targets and novel therapeutic products.

For more information about partnering with Compugen, please contact bd@cgen.com